Delivery Order SPE2DB22D1106-SPE2DB25FFGQ7
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings valued at $1,255.38. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under a larger procurement...
- The Defense Logistics Agency awarded a $1,496.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of June 9, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of etonogestrel-ethinyl estradiol vaginal rings, with a ceiling value of $1,165.71. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,687.77 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol (EE) vaginal rings on August 12, 2025, with a completion date of August 13, 2025. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings valued at $1,793.40 under a firm fixed price contract type. The award, made on August 12, 2025, represents a single delivery order with an ultimate completion date of August 13, 2025, and involves no set-aside designation, indicating competitive award. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,354.82 to AmerisourceBergen Drug Corp for Etonogestrel-EE vaginal rings, with a completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,228.12 to AmerisourceBergen Drug Corp for the supply of etonogestrel-ethinyl estradiol vaginal rings, with an ultimate completion date of July 22, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded a $3,586.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings, with a completion date of September 15, 2025. This delivery order, issued on September 12, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, direct order placed against AmerisourceBergen's existing contract vehicle with the DLA. This delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,254.15 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings. This order, issued on May 30, 2025, with completion targeted for June 2, 2025, represents a small-value pharmaceutical supply transaction supporting federal medical procurement needs. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp will perform this work from its...
- The Defense Logistics Agency awarded a delivery order valued at $3,625.98 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings on August 19, 2025, with completion scheduled for August 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract utilizes firm fixed pricing with no set-aside designation,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGQ7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,076.04 to AmerisourceBergen Drug Corp for etonogestrel-ethinyl estradiol vaginal rings under a firm fixed price contract. This delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a child contract action under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The award carries no set-aside designation, indicating it was competitively awarded. Performance will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supplier, holds a significant $999,999,999.00 indefinite delivery contract (SPE2DX) with DLA Troop Support Medical through December 2026. This prime vendor agreement enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The current delivery order for contraceptive vaginal rings represents a routine fulfillment under this expansive pharmaceutical support vehicle, reflecting AmerisourceBergen's established capability to meet federal medical procurement requirements across diverse therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/3/25 |